Keywords: USA, Australia, CSL, Baxter, Behring, Blood plasma, Law suit Medicines Australia

Class action against Australia’s CSL widens with US university claimant; Medicines Australia appoints permanent CEO

Article | 11 January 2010

Print This

Action against Australian plasma and vaccines producer CSL has continued to accelerate, since the US Federal Trade Commission blocked the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in